Diagnostic and therapeutic approaches for endometriosis: a patent landscape.
Adenomyosis
Diagnostics
Endometriosis
Patent
Therapeutics
Journal
Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213
Informations de publication
Date de publication:
25 Aug 2023
25 Aug 2023
Historique:
received:
13
01
2023
accepted:
09
07
2023
medline:
26
8
2023
pubmed:
26
8
2023
entrez:
25
8
2023
Statut:
aheadofprint
Résumé
The aim of this review is to analyze the patent filings and to systematize the main technological trends in patent protection for the diagnosis and therapeutics for endometriosis. Patent literature has also been explored to identify active inventors and applicants in this field. Patent search was carried out in the freely accessible patent search databases namely, patentscope using various combinations of the keywords "Endometriosis OR Adenomyosis" AND "Diagnostic OR Therapeutics" were used along with wildcard search queries in the "Title", "Abstract" and "Descriptions" fields. A patent search revealed 144 patents describing inventions for diagnostic and therapeutic purposes of endometriosis. These patents include 26 patent applications in the diagnostic utility and 116 patent applications under the therapeutic approaches. Out of these 116 patent applications, 43 describe traditional medicines for endometriosis. Two patent applications describe inventions that can fall into both categories. Efforts are being made to improve current diagnostic instruments. Hormonal alteration methods is the most common field of invention, followed by surgical interventions for therapeutics. A general trend of increase in patent application filings has been observed with a slight decrease in recent years.
Identifiants
pubmed: 37626175
doi: 10.1007/s00404-023-07151-0
pii: 10.1007/s00404-023-07151-0
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Saunders PTK, Horne AW (2021) Endometriosis: etiology, pathobiology, and therapeutic prospects. Cell 184:2807–2824. https://doi.org/10.1016/j.cell.2021.04.041
doi: 10.1016/j.cell.2021.04.041
pubmed: 34048704
Giudice LC, Kao LC (2004) Endometriosis. Lancet 364:1789–1799. https://doi.org/10.1016/S0140-6736(04)17403-5
doi: 10.1016/S0140-6736(04)17403-5
pubmed: 15541453
Meuleman C, Vandenabeele B, Fieuws S et al (2009) High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril 92:68–74. https://doi.org/10.1016/j.fertnstert.2008.04.056
doi: 10.1016/j.fertnstert.2008.04.056
pubmed: 18684448
Smolarz B, Szyłło K, Romanowicz H (2021) Endometriosis: epidemiology, classification, pathogenesis, treatment and genetics (review of literature). Int J Mol Sci 22:10554. https://doi.org/10.3390/ijms221910554
doi: 10.3390/ijms221910554
pubmed: 34638893
pmcid: 8508982
Mehedintu C, Plotogea M, Ionescu S, Antonovici M (2014) Endometriosis still a challenge. J Med Life 7:349–357
pubmed: 25408753
pmcid: 4233437
Hsu AL, Khachikyan I, Stratton P (2010) Invasive and noninvasive methods for the diagnosis of endometriosis. Clin Obstet Gynecol 53:413–419. https://doi.org/10.1097/GRF.0b013e3181db7ce8
doi: 10.1097/GRF.0b013e3181db7ce8
pubmed: 20436318
pmcid: 2880548
Kido A, Himoto Y, Moribata Y et al (2022) MRI in the diagnosis of endometriosis and related diseases. Korean J Radiol 23:426. https://doi.org/10.3348/kjr.2021.0405
doi: 10.3348/kjr.2021.0405
pubmed: 35289148
pmcid: 8961012
Sahin C, Mamillapalli R, Yi KW, Taylor HS (2018) microRNA Let-7b: a novel treatment for endometriosis. J Cell Mol Med 22:5346–5353. https://doi.org/10.1111/jcmm.13807
doi: 10.1111/jcmm.13807
pubmed: 30063121
pmcid: 6201226
Levy AR, Osenenko KM, Lozano-Ortega G et al (2011) Economic burden of surgically confirmed endometriosis in Canada. J Obstet Gynaecol Can JOGC 33:830–837. https://doi.org/10.1016/S1701-2163(16)34986-6
doi: 10.1016/S1701-2163(16)34986-6
pubmed: 21846438
Brown J, Kives S, Akhtar M (2012) Progestogens and anti-progestogens for pain associated with endometriosis. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD002122.pub2
doi: 10.1002/14651858.CD002122.pub2
pubmed: 23152210
pmcid: 6544775
Angioni S, Cofelice V, Pontis A et al (2014) New trends of progestins treatment of endometriosis. Gynecol Endocrinol 30:769–773. https://doi.org/10.3109/09513590.2014.950646
doi: 10.3109/09513590.2014.950646
pubmed: 25144122
Ozkan S, Arici A (2009) Advances in treatment options of endometriosis. Gynecol Obstet Investig 67:81–91. https://doi.org/10.1159/000163071
doi: 10.1159/000163071
Vannuccini S, Clemenza S, Rossi M, Petraglia F (2022) Hormonal treatments for endometriosis: the endocrine background. Rev Endocr Metab Disord 23:333–355. https://doi.org/10.1007/s11154-021-09666-w
doi: 10.1007/s11154-021-09666-w
pubmed: 34405378
Wu Y, Zhu Y, Xie N et al (2022) A network pharmacology approach to explore active compounds and pharmacological mechanisms of a patented Chinese herbal medicine in the treatment of endometriosis. PLoS ONE 17:e0263614. https://doi.org/10.1371/journal.pone.0263614
doi: 10.1371/journal.pone.0263614
pubmed: 35130311
pmcid: 8820622
Nirgianakis K, Egger K, Kalaitzopoulos DR et al (2022) Effectiveness of dietary interventions in the treatment of endometriosis: a systematic review. Reprod Sci 29:26–42. https://doi.org/10.1007/s43032-020-00418-w
doi: 10.1007/s43032-020-00418-w
pubmed: 33761124
YalçınBahat P, Ayhan I, ÜreyenÖzdemir E et al (2022) Dietary supplements for treatment of endometriosis: a review. Acta Bio-medica Atenei Parmensis 93(1):e2022159. https://doi.org/10.23750/abm.v93i1.11237
doi: 10.23750/abm.v93i1.11237
Smolarz B, Szyłło K, Romanowicz H (2020) The genetic background of endometriosis: can ESR2 and CYP19A1 genes be a potential risk factor for its development? Int J Mol Sci 21:8235. https://doi.org/10.3390/ijms21218235
doi: 10.3390/ijms21218235
pubmed: 33153202
pmcid: 7663510
Ruiz A, Ruiz L, Colón-Caraballo M et al (2018) Pharmacological blockage of the CXCR4–CXCL12 axis in endometriosis leads to contrasting effects in proliferation, migration, and invasion†. Biol Reprod 98:4–14. https://doi.org/10.1093/biolre/iox152
doi: 10.1093/biolre/iox152
pubmed: 29161347
Ragni E, Colombini A, De Luca P et al (2021) miR-103a-3p and miR-22-5p are reliable reference genes in extracellular vesicles from cartilage, adipose tissue, and bone marrow cells. Front Bioeng Biotechnol 9:632440. https://doi.org/10.3389/fbioe.2021.632440
doi: 10.3389/fbioe.2021.632440
pubmed: 33659243
pmcid: 7917212
Yuguchi H, Tanabe A, Hayashi A et al (2013) The expression status of G protein-coupled receptor GPR30 is associated with the clinical characteristics of endometriosis. Endocr Res 38:223–231. https://doi.org/10.3109/07435800.2013.774011
doi: 10.3109/07435800.2013.774011
pubmed: 23458722
Karimi-Zarchi M, Dehshiri-Zadeh N, Sekhavat L, Nosouhi F (2016) Correlation of CA-125 serum level and clinico-pathological characteristic of patients with endometriosis. Int J Reprod Biomed 14:713–718
pubmed: 28008424
pmcid: 5153578
Ponomarenko I, Reshetnikov E, Polonikov A et al (2021) Candidate genes for age at menarche are associated with uterine leiomyoma. Front Genet 11:512940. https://doi.org/10.3389/fgene.2020.512940
doi: 10.3389/fgene.2020.512940
pubmed: 33552117
pmcid: 7863975
Li S, Fu X, Wu T et al (2017) Role of interleukin-6 and its receptor in endometriosis. Med Sci Monit 23:3801–3807. https://doi.org/10.12659/MSM.905226
doi: 10.12659/MSM.905226
pubmed: 28779573
pmcid: 5556658
Mathur SP, Holt VL, Lee JH et al (1998) Levels of antibodies to transferrin and alpha 2-HS glycoprotein in women with and without endometriosis. Am J Reprod Immunol (New York, N.Y.: 1989) 40(2):69–73. https://doi.org/10.1111/j.1600-0897.1998.tb00393.x
doi: 10.1111/j.1600-0897.1998.tb00393.x
Chao X, Liu Y, Fan Q et al (2021) The role of the vaginal microbiome in distinguishing female chronic pelvic pain caused by endometriosis/adenomyosis. Ann Transl Med 9:771. https://doi.org/10.21037/atm-20-4586
doi: 10.21037/atm-20-4586
pubmed: 34268384
pmcid: 8246188
Gratton S-M, Choudhry AJ, Vilos GA et al (2022) Diagnosis of endometriosis at laparoscopy: a validation study comparing surgeon visualization with histologic findings. J Obstet Gynaecol Can 44:135–141. https://doi.org/10.1016/j.jogc.2021.08.013
doi: 10.1016/j.jogc.2021.08.013
pubmed: 34562632
Mettler L, Schollmeyer T, Lehmann-Willenbrock E et al (2003) Accuracy of laparoscopic diagnosis of endometriosis. JSLS 7:15–18
pubmed: 12722993
pmcid: 3015470
Alborzi S, Rasekhi A, Shomali Z et al (2018) Diagnostic accuracy of magnetic resonance imaging, transvaginal, and transrectal ultrasonography in deep infiltrating endometriosis. Medicine (Baltimore) 97:e9536. https://doi.org/10.1097/MD.0000000000009536
doi: 10.1097/MD.0000000000009536
pubmed: 29465552
Philip C-A, Warembourg S, Dairien M et al (2020) Transrectal high-intensity focused ultrasound (HIFU) for management of rectosigmoid deep infiltrating endometriosis: results of phase-I clinical trial. Ultrasound Obstet Gynecol 56:431–442. https://doi.org/10.1002/uog.21937
doi: 10.1002/uog.21937
pubmed: 31788875
Di Spiezio SA, Calagna G, Santangelo F et al (2017) The role of hysteroscopy in the diagnosis and treatment of adenomyosis. BioMed Res Int 2017:1–7. https://doi.org/10.1155/2017/2518396
doi: 10.1155/2017/2518396
Ozkan ZS, Cilgin H, Simsek M et al (2013) Investigation of apelin expression in endometriosis. J Reprod Infertil 14:50–55
pubmed: 23926564
pmcid: 3719321
Frontiers|A natural xenogeneic endometrial extracellular matrix hydrogel toward improving current human in vitro models and future in vivo applications. https://www.frontiersin.org/articles/ https://doi.org/10.3389/fbioe.2021.639688/full . Accessed 4 Nov 2022
Zanelotti A, Decherney AH (2017) Surgery and endometriosis. Clin Obstet Gynecol 60:477–484. https://doi.org/10.1097/GRF.0000000000000291
doi: 10.1097/GRF.0000000000000291
pubmed: 28742580
pmcid: 5635831
Dai Y, Li X, Shi J, Leng J (2018) A review of the risk factors, genetics and treatment of endometriosis in Chinese women: a comparative update. Reprod Health 15:82. https://doi.org/10.1186/s12978-018-0506-7
doi: 10.1186/s12978-018-0506-7
pubmed: 29783992
pmcid: 5963030
Hughes E, Brown J, Collins JJ et al (2007) Ovulation suppression for endometriosis for women with subfertility. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD000155.pub2
doi: 10.1002/14651858.CD000155.pub2
pubmed: 17943896
pmcid: 7045467
Chantalat E, Valera M-C, Vaysse C et al (2020) Estrogen receptors and endometriosis. Int J Mol Sci 21:2815. https://doi.org/10.3390/ijms21082815
doi: 10.3390/ijms21082815
pubmed: 32316608
pmcid: 7215544
Gezer A, Oral E (2015) Progestin therapy in endometriosis. Womens Health 11:643–652. https://doi.org/10.2217/whe.15.42
doi: 10.2217/whe.15.42
Rafique S, DeCherney AH (2017) Medical management of endometriosis. Clin Obstet Gynecol 60:485–496. https://doi.org/10.1097/GRF.0000000000000292
doi: 10.1097/GRF.0000000000000292
pubmed: 28590310
pmcid: 5794019
Mettler L, Ruprai R, Alkatout I (2014) Impact of medical and surgical treatment of endometriosis on the cure of endometriosis and pain. BioMed Res Int 2014:264653. https://doi.org/10.1155/2014/264653
doi: 10.1155/2014/264653
pubmed: 25580428
pmcid: 4279262
Muraoka A, Osuka S, Yabuki A et al (2021) Impact of perioperative use of GnRH agonist or dienogest on ovarian reserve after cystectomy for endometriomas: a randomized controlled trial. Reprod Biol Endocrinol 19:179. https://doi.org/10.1186/s12958-021-00866-2
doi: 10.1186/s12958-021-00866-2
pubmed: 34872568
pmcid: 8647468
Küpker W, Felberbaum RE, Krapp M et al (2002) Use of GnRH antagonists in the treatment of endometriosis. Reprod Biomed Online 5:12–16. https://doi.org/10.1016/s1472-6483(10)61590-8
doi: 10.1016/s1472-6483(10)61590-8
pubmed: 12470539
Schweppe K-W (2001) Current place of progestins in the treatment of endometriosis-related complaints. Gynecol Endocrinol 15:22–28. https://doi.org/10.1080/gye.15.s6.22.28
doi: 10.1080/gye.15.s6.22.28
pubmed: 12227883
Schindler AE (2011) Dienogest in long-term treatment of endometriosis. Int J Womens Health 3:175–184. https://doi.org/10.2147/IJWH.S5633
doi: 10.2147/IJWH.S5633
pubmed: 21792339
pmcid: 3140813
Qu F (2006) Effects of Yiweining Recipe on expressions of metalloproteinase-2 and cyclooxygenase-2 mRNAs in ectopic endometrium of rats with endometriosis. J Chin Integr Med. https://doi.org/10.3736/jcim20060619
doi: 10.3736/jcim20060619
Harada T, Iwabe T, Terakawa N (2001) Role of cytokines in endometriosis. Fertil Steril 76:1–10. https://doi.org/10.1016/S0015-0282(01)01816-7
doi: 10.1016/S0015-0282(01)01816-7
pubmed: 11438312
Kato T, Yasuda K, Matsushita K et al (2019) Interleukin-1/-33 signaling pathways as therapeutic targets for endometriosis. Front Immunol 10:2021. https://doi.org/10.3389/fimmu.2019.02021
doi: 10.3389/fimmu.2019.02021
pubmed: 31507610
pmcid: 6714064
Lu P, Takai K, Weaver VM, Werb Z (2011) Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol 3:a005058–a005058. https://doi.org/10.1101/cshperspect.a005058
doi: 10.1101/cshperspect.a005058
pubmed: 21917992
pmcid: 3225943
Günal MY, Ozansoy M, Kılıç Ü et al (2019) Role of erythropoietin and its receptor in the development of endometriosis in rats. J Turk Ger Gynecol Assoc 20:41–46. https://doi.org/10.4274/jtgga.galenos.2018.2018.0039
doi: 10.4274/jtgga.galenos.2018.2018.0039
pubmed: 29916217
pmcid: 6501872
Stringer EM, Fleming GF (2013) Hormone therapy plus mTOR inhibitors in the treatment of endometrial carcinoma. Oncol Hematol Rev 9(1):41–44. https://doi.org/10.17925/ohr.2013.09.1.41
doi: 10.17925/ohr.2013.09.1.41
pubmed: 25431800
pmcid: 4243922
Gainer EE, Ulmann A (2003) Pharmacologic properties of CDB(VA)-2914. Steroids 68:1005–1011. https://doi.org/10.1016/S0039-128X(03)00130-2
doi: 10.1016/S0039-128X(03)00130-2
pubmed: 14667993
Xu H, Becker CM, Lui WT et al (2011) Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo. Fertil Steril 96:1021-1028.e1. https://doi.org/10.1016/j.fertnstert.2011.07.008
doi: 10.1016/j.fertnstert.2011.07.008
pubmed: 21821246
Koppitz M, Bräuer N, Ter Laak A et al (2019) Discovery and optimization of pyridyl-cycloalkyl-carboxylic acids as inhibitors of microsomal prostaglandin E synthase-1 for the treatment of endometriosis. Bioorg Med Chem Lett 29:2700–2705. https://doi.org/10.1016/j.bmcl.2019.07.007
doi: 10.1016/j.bmcl.2019.07.007
pubmed: 31362919
Foster PA (2021) Steroid sulphatase and its inhibitors: past, present, and future. Molecules 26:2852. https://doi.org/10.3390/molecules26102852
doi: 10.3390/molecules26102852
pubmed: 34064842
pmcid: 8151039
Noble LS, Takayama K, Zeitoun KM et al (1997) Prostaglandin E
doi: 10.1210/jcem.82.2.3783
pubmed: 9024261
Murakami K, Nomura K, Shinohara K et al (2006) Danazol inhibits aromatase activity of endometriosis-derived stromal cells by a competitive mechanism. Fertil Steril 86:291–297. https://doi.org/10.1016/j.fertnstert.2005.12.074
doi: 10.1016/j.fertnstert.2005.12.074
pubmed: 16806212
Piacenti I, Viscardi MF, Masciullo L et al (2021) Dienogest versus continuous oral levonorgestrel/EE in patients with endometriosis: what’s the best choice? Gynecol Endocrinol 37:471–475. https://doi.org/10.1080/09513590.2021.1892632
doi: 10.1080/09513590.2021.1892632
pubmed: 33650928
Ilhan M, Dereli FTG, Akkol EK (2019) Novel drug targets with traditional herbal medicines for overcoming endometriosis. Curr Drug Deliv 16:386–399. https://doi.org/10.2174/1567201816666181227112421
doi: 10.2174/1567201816666181227112421
pubmed: 30588884
pmcid: 6637095
Wieser F, Cohen M, Gaeddert A et al (2007) Evolution of medical treatment for endometriosis: back to the roots? Hum Reprod Update 13:487–499. https://doi.org/10.1093/humupd/dmm015
doi: 10.1093/humupd/dmm015
pubmed: 17575287
Wieser F, Yu J, Park J et al (2009) A botanical extract from channel flow inhibits cell proliferation, induces apoptosis, and suppresses CCL5 in human endometriotic stromal cells1. Biol Reprod 81:371–377. https://doi.org/10.1095/biolreprod.108.075069
doi: 10.1095/biolreprod.108.075069
pubmed: 19403929
Chapron C, Marcellin L, Borghese B, Santulli P (2019) Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol 15:666–682. https://doi.org/10.1038/s41574-019-0245-z
doi: 10.1038/s41574-019-0245-z
pubmed: 31488888
Clemenza S, Sorbi F, Noci I et al (2018) From pathogenesis to clinical practice: emerging medical treatments for endometriosis. Best Pract Res Clin Obstet Gynaecol 51:92–101. https://doi.org/10.1016/j.bpobgyn.2018.01.021
doi: 10.1016/j.bpobgyn.2018.01.021
pubmed: 29559388
Simsa P, Mihalyi A, Kyama CM et al (2007) Future of endometriosis research. Womens Health 3:647–654. https://doi.org/10.2217/17455057.3.5.647
doi: 10.2217/17455057.3.5.647
Pavone ME, Bulun SE (2012) Aromatase inhibitors for the treatment of endometriosis. Fertil Steril 98:1370–1379. https://doi.org/10.1016/j.fertnstert.2012.08.053
doi: 10.1016/j.fertnstert.2012.08.053
pubmed: 22999792
pmcid: 3513666
Hudson QJ, Proestling K, Perricos A et al (2021) The role of long non-coding RNAs in endometriosis. Int J Mol Sci 22:11425. https://doi.org/10.3390/ijms222111425
doi: 10.3390/ijms222111425
pubmed: 34768856
pmcid: 8583837
Miller JE, Monsanto SP, Ahn SH et al (2017) Interleukin-33 modulates inflammation in endometriosis. Sci Rep 7(1):17903. https://doi.org/10.1038/s41598-017-18224-x
doi: 10.1038/s41598-017-18224-x
pubmed: 29263351
pmcid: 5738435
Motavalli R, Majidi T, Pourlak T el al (2021) The clinical significance of the glucocorticoid receptors: Genetics and epigenetics. J Steroid Biochem Mol Biol 213:105952. https://doi.org/10.1016/j.jsbmb.2021.105952
doi: 10.1016/j.jsbmb.2021.105952
pubmed: 34274458
Margatho D, Carvalho NM, Bahamondes L (2020) Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months. Eur J Contracept Reprod Health Care 25(2):133–140. https://doi.org/10.1080/13625187.2020.1725461
doi: 10.1080/13625187.2020.1725461
pubmed: 32069126
de Freitas Fonseca M, Aragao LC, Sessa FV et al (2018) Interrelationships among endometriosis-related pain symptoms and their effects on health-related quality of life: a sectional observational study. Obstet Gynecol Sci. 61(5):605–614. https://doi.org/10.5468/ogs.2018.61.5.605
doi: 10.5468/ogs.2018.61.5.605